JPRN-jRCT1080222395未知Unknown
Sonias Combination Tablets LD special drug use surveillance Survey on Type 2 diabetes mellitus: Insufficient treatment response to Pioglitazone
TAKEDA PHARMACEUTICAL COMPANY LTD.0 个研究点目标入组 210 人开始时间: 2014年2月17日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 发起方
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with type 2 diabetes mellitus for whom treatment with pioglitazone hydrochloride monotherapy (pioglitazone at 15 mg/day) is considered inefficacious as per physician's assessment and for whom long-term treatment with Sonias Combination Tablets LD is considered necessary
排除标准
- •(1) Patients with cardiac failure or a history of cardiac failure
- •(2) Patients with serious hepatic or renal impairment
- •(3) Patients with severe ketosis, diabetic coma or precoma, or type 1 diabetes mellitus
- •(4) Patients with severe infection, severe trauma, or pre- and post-operative patients
- •(5) Patients with gastrointestinal disorders such as diarrhea and vomiting
- •(6) Pregnant or potentially pregnant women
- •(7) Patients with a history of hypersensitivity to the ingredients in Sonias Combination Tablets or sulfonamides
研究者
相似试验
未知
Unknown
nisia Combination Tablets LD, HD Special Drug Use Surveillance Hypertension: Long-Term UseHypertensionJPRN-jRCT1080222340TAKEDA PHARMACEUTICAL COMPANY LTD.3,000
未知
Unknown
iovel Combination Tablets special drug use surveillance Long-term use in patients with type 2 diabetes mellitusJPRN-jRCT1080222253TAKEDA PHARMACEUTICAL COMPANY LTD.3,000
进行中（未招募）
不适用
Special Drug Use-results Survey of RIONA Tablets (Pregnant Patients with Iron Deficiency Anemia)Iron deficiency anaemiaJPRN-jRCT2031210322Dept. and Pharmacovigilance Patient Safety100
未知
Unknown
ECARD Combination Tablets LD&HD special drug use surveillance: Long-term use (12 months)HypertensionJPRN-jRCT1080222313TAKEDA PHARMACEUTICAL COMPANY LTD.3,000
未知
Unknown
esina tablets special drug use surveillance Type 2 diabetes mellitus: Combination therapy with thiazolidinedionesJPRN-jRCT1080222218TAKEDA PHARMACEUTICAL COMPANY LTD.1,000